{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T17:02:20Z","timestamp":1773680540041,"version":"3.50.1"},"reference-count":33,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Malignant pleural mesothelioma (MPM) is a rare tumor with poor prognosis. Several studies have analyzed potential prognostic markers, but histologic type remains the single most important prognostic factor. Histologic subtypes of epithelioid MPM seem to have prognostic and therapeutic implications. Interobserver agreement in histologic pattern classification should be high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To assess interobserver and intraobserver reproducibility in histologic differentiation between the main types of MPMs, and in further subtyping of epithelioid-type mesothelioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>One representative hematoxylin-eosin\u2013stained slide was selected from the archive for each of 200 patients with MPM. They were reviewed independently by 3 pathologists and classified according to the current World Health Organization classification of pleural tumors. After the first round of evaluations, a consensus meeting was organized where problems were addressed and representative images for each histologic category were selected. Two months later, cases were reevaluated by all 3 pathologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>After the first round, overall interobserver agreement for histologic subtyping of mesothelioma was fair (\u03ba, 0.36). The agreement was increased to substantial (\u03ba, 0.63) in the second round. Improvement was found in interobserver agreement for all types of MPM and for most epithelioid subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Moderate to substantial agreement in histologic typing and subtyping of MPM can be achieved. However, training with additional clarification of diagnostic criteria, their strict application, and help from consensus-based illustrative images is needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2017-0295-oa","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T09:18:04Z","timestamp":1520327884000},"page":"747-752","source":"Crossref","is-referenced-by-count":25,"title":["Reproducibility of Malignant Pleural Mesothelioma Histopathologic Subtyping"],"prefix":"10.5858","volume":"142","author":[{"given":"Luka","family":"Brcic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregor","family":"Vlacic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Quehenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izidor","family":"Kern","sequence":"additional","affiliation":[{"name":"From the Institute of Pathology (Dr Brcic) and the Institute for Medical Informatics, Statistics and Documentation (Dr Quehenberger), Medical University of Graz, Graz, Austria; and Cytology and Pathology Laboratory, University Clinic of Respiratory and Allergic Diseases, Golnik, Slovenia (Drs Vlacic and Kern)."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2018,3,6]]},"reference":[{"key":"2020081217415828400_i1543-2165-142-6-747-b01","article-title":"SEER cancer statistics review 1975-2013, mesothelioma","author":"The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute","year":"2016"},{"issue":"15","key":"2020081217415828400_i1543-2165-142-6-747-b02","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"2020081217415828400_i1543-2165-142-6-747-b03","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemiol"},{"issue":"5","key":"2020081217415828400_i1543-2165-142-6-747-b04","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11748-011-0915-9","article-title":"Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals","volume":"60","author":"Bille","year":"2012","journal-title":"Gen Thorac Cardiovasc Surg"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b05","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2214\/AJR.11.7015","article-title":"Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume","volume":"198","author":"Gill","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"2020081217415828400_i1543-2165-142-6-747-b06","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ctrv.2015.05.001","article-title":"The established and future biomarkers of malignant pleural mesothelioma","volume":"41","author":"Panou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"2020081217415828400_i1543-2165-142-6-747-b07","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejca.2016.04.018","article-title":"Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma\u2014a multi-institutional study","volume":"63","author":"Hoda","year":"2016","journal-title":"Eur J Cancer"},{"issue":"11","key":"2020081217415828400_i1543-2165-142-6-747-b08","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","article-title":"Initial analysis of the international association for the study of lung cancer mesothelioma database","volume":"7","author":"Rusch","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2020081217415828400_i1543-2165-142-6-747-b09","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jss.2015.01.043","article-title":"Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database","volume":"196","author":"Meyerhoff","year":"2015","journal-title":"J Surg Res"},{"key":"2020081217415828400_i1543-2165-142-6-747-b10","article-title":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae)","journal-title":"Malignant Pleural Mesothelioma, version 2.2017"},{"key":"2020081217415828400_i1543-2165-142-6-747-b11","first-page":"156","article-title":"Diffuse malignant mesothelioma","author":"Galateau-Salle","year":"2015","journal-title":"WHO Classifiction of Tumours of the Lung, Pleura, Thymus and Heart"},{"issue":"6","key":"2020081217415828400_i1543-2165-142-6-747-b12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00428-014-1664-9","article-title":"Reproducibility of histological subtyping of malignant pleural mesothelioma","volume":"465","author":"Br\u010di\u0107","year":"2014","journal-title":"Virchows Arch"},{"issue":"5","key":"2020081217415828400_i1543-2165-142-6-747-b13","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/JTO.0b013e318211127a","article-title":"Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma","volume":"6","author":"Kadota","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"7","key":"2020081217415828400_i1543-2165-142-6-747-b14","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2012.39","article-title":"Pleomorphic mesothelioma: report of 10 cases","volume":"25","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Mod Pathol"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jclinpath-2016-203993","article-title":"Myxoid variant epithelioid pleural mesothelioma defines a favourable prognosis group: an analysis of 191 patients with pleural malignant mesothelioma","volume":"70","author":"Alchami","year":"2017","journal-title":"J Clin Pathol"},{"issue":"11\u201312","key":"2020081217415828400_i1543-2165-142-6-747-b16","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0344-0338(97)80054-4","article-title":"Malignant mesothelioma of the pleura: the reproducibility of the immunohistological diagnosis","volume":"193","author":"Betta","year":"1997","journal-title":"Pathol Res Pract"},{"issue":"9","key":"2020081217415828400_i1543-2165-142-6-747-b17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jcp.48.9.856","article-title":"Malignant mesothelioma of the pleura: interobserver variability","volume":"48","author":"Andrion","year":"1995","journal-title":"J Clin Pathol"},{"issue":"5","key":"2020081217415828400_i1543-2165-142-6-747-b18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2559.1994.tb00004.x","article-title":"Differentiation of adenocarcinoma of the lung and malignant mesothelioma: predictive value and reproducibility of immunoreactive antibodies","volume":"25","author":"Skov","year":"1994","journal-title":"Histopathology"},{"issue":"5","key":"2020081217415828400_i1543-2165-142-6-747-b19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5858\/arpa.2012-0214-OA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group","volume":"137","author":"Husain","year":"2013","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2020081217415828400_i1543-2165-142-6-747-b20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.5858\/2005-129-1415-ROHPOD","article-title":"Recognition of histopathologic patterns of diffuse malignant mesothelioma in differential diagnosis of pleural biopsies","volume":"129","author":"Allen","year":"2005","journal-title":"Arch Pathol Lab Med"},{"issue":"1","key":"2020081217415828400_i1543-2165-142-6-747-b21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","article-title":"The measurement of observer agreement for categorical data","volume":"33","author":"Landis","year":"1977","journal-title":"Biometrics"},{"issue":"7","key":"2020081217415828400_i1543-2165-142-6-747-b22","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/PAS.0000000000000394","article-title":"BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations","volume":"39","author":"Sheffield","year":"2015","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"2020081217415828400_i1543-2165-142-6-747-b23","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.jtho.2016.06.020","article-title":"BRCA1-associated protein 1 (BAP1) immunohistochemical expression as a diagnostic tool in malignant pleural mesothelioma classification: a large retrospective study","volume":"11","author":"Righi","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"World Health Organization Committee for Tumors of the Pleura. The 2015 World Health Organization Classification of Tumors of the Pleura: advances since the 2004 classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"issue":"8","key":"2020081217415828400_i1543-2165-142-6-747-b25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/PAS.0000000000000246","article-title":"Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation","volume":"38","author":"Kadota","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"41","key":"2020081217415828400_i1543-2165-142-6-747-b26","doi-asserted-by":"crossref","first-page":"67302","DOI":"10.18632\/oncotarget.11693","article-title":"Quantitative image variables reflect the intratumoral pathologic heterogeneity of lung adenocarcinoma","volume":"7","author":"Choi","year":"2016","journal-title":"Oncotarget"},{"issue":"4","key":"2020081217415828400_i1543-2165-142-6-747-b27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/JTO.0b013e3182828fb8","article-title":"Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC\/ATS\/ERS lung adenocarcinoma classification in stage III (N2) patients","volume":"8","author":"Russell","year":"2013","journal-title":"J Thorac Oncol"},{"issue":"8","key":"2020081217415828400_i1543-2165-142-6-747-b28","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/0046-8177(95)90010-1","article-title":"Histological grading of breast carcinomas: a study of interobserver agreement","volume":"26","author":"Robbins","year":"1995","journal-title":"Hum Pathol"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b29","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO;2-7","article-title":"Reproducibility of a histopathologic grading system for adult soft tissue sarcoma","volume":"58","author":"Coindre","year":"1986","journal-title":"Cancer"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00428-012-1263-6","article-title":"Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC\/ATS\/ERS classification","volume":"461","author":"Warth","year":"2012","journal-title":"Virchows Arch"},{"issue":"5","key":"2020081217415828400_i1543-2165-142-6-747-b31","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1183\/09031936.00219211","article-title":"Interobserver variability in the application of the novel IASLC\/ATS\/ERS classification for pulmonary adenocarcinomas","volume":"40","author":"Warth","year":"2012","journal-title":"Eur Respir J"},{"issue":"2","key":"2020081217415828400_i1543-2165-142-6-747-b32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1066896913519165","article-title":"Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern","volume":"22","author":"Wang","year":"2014","journal-title":"Int J Surg Pathol"},{"issue":"12","key":"2020081217415828400_i1543-2165-142-6-747-b33","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/modpathol.2012.106","article-title":"Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma: an international interobserver study","volume":"25","author":"Thunnissen","year":"2012","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/747\/1447859\/arpa_2017-0295-oa.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/142\/6\/747\/1447859\/arpa_2017-0295-oa.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:34:21Z","timestamp":1764790461000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/142\/6\/article-p747.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,6]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,3,6]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2017-0295-oa","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,6]]}}}